Publication: 2301

Randomized phase II study comparing the met inhibitor cabozantinib to temozolomide (tmz) or dacarbazine (dtic) in ocular melanoma - A091201
      Google Scholar   
Citation:
J Clin Oncol vol 33 (suppl) abstr TPS9087
Meeting Instance:
ASCO 2015
Year:
2015
Type:
Abstract
Sub type:
Poster General
Funding:
NCTN
Endpoint:
No-Endpoint
Analysis:
Trial-Description-Only
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Parents:
None
Children:
3092  
Program:
OGC
Primary Committee:
Experimental
Sec. Committees:
   
Pharmas:
 
Grants:
 
Corr. Author:
 
Authors:
             
Networks:
COLUMBIA, LAPS-MN026, LAPS-PA015   
Study
Alliance-A091201
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords: